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ABSTRACT
Objective: To assess the predictors of C-reactive protein response in plasmodium 
falciparum malaria as seen in children in a malaria endemic region of Nigeria.
Design: A prospective cross-sectional study.
Setting : The Children Out-patient (CHOP) Clinic, Children Emergency Unit (CHEU), 
Child Welfare/Growth Monitoring Clinic, Immunisation Centre and Paediatric Ward 
of the University of Uyo Teaching Hospital (UUTH), Uyo in Akwa-Ibom State.  
Subjects : Three hundred and sixty children aged six to sixty months with microscopically 
confirmed P. falciparum malaria compared with 360 healthy children without malaria 
parasitaemia matched for age and gender.
Results: The predictors of the C-reactive protein response in malaria (CRP ≥ 10mg/l) 
were fever (t = 6.867; p = 0.001), malaria parasite count (t = 5.387; p = 0.001), severe 
anaemia (t = -11.23; p = 0.001) and age. Younger children had a greater CRP response. 
The logistic regression curve showed a 66.9% sensitivity, 92.1% specificity, positive 
predictive value, 83.2% and negative predictive value of 82.2% of predicting C-reactive 
protein response in malaria. 
Conclusion: P. falciparum malaria induces significant CRP responses. Younger children 
who present with fever, hyperparasitaemia and severe anaemia are more likely to have 
C-reactive protein response with malaria.
INTRODUCTION
The global burden of malarial disease and its 
complications in childhood still constitutes a major 
public health problem and calls for sustained efforts 
towards its control. The pathophysiological response 
of individuals to malaria is highly variable. It depends 
on several factors including previously acquired 
immunity and the production of cytokines (1,2). Host 
immune markers of inflammation like C-reactive 
protein (CRP) which is a non-specific acute phase 
reactant, has been found to play an important role in 
the immune responses to malaria (3). Its measurement 
therefore has physiological relevance as an indirect 
measure of inflammatory events that occur during 
malaria infection (4). A prospective characterisation 
of CRP levels during malaria infection could provide 
additional insight to its pattern of response in the 
disease. 
 Various host and parasite factors are responsible 
for the pathological events seen in malaria. At the 
completion of schizogony within red blood cells, 
newly developed merozoites are released, and 
alongside numerous waste substances and toxic 
factors such as glycosylphosphatidylinositol (GPI) 
into the blood (5,6). The vigorous cytokine responses 
to parasite proteins released during schizogony 
contributes to adverse clinical outcomes. Severe 
malaria has been associated with high levels of 
inflammatory cytokines such as Tumour necrotic 
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factor-α, Interleukin-I and Interleukin-6, and these 
cytokines induce the production of C-reactive protein 
from hepatocytes (5,6).
 In hyperendemic or holoendemic malarial 
areas in sub-Saharan Africa, including Nigeria, 
these immunological markers may serve as useful 
indicators for active malarial episodes (7,8). There 
is an association of elevated levels of C-reactive 
protein in uncomplicated and severe forms of 
malaria. Therefore, knowledge of C-reactive protein 
response may be useful as a tool in malaria immuno-
epidemiology, serving as a malaria episode marker 
for use in government and non-governmental 
malaria control programmes. Recent studies on new 
therapeutic agents that lower the circulating CRP 
levels might also open up new adjuncts to treatment 
options against malaria to reduce its incidence and 
promote better health among children in Nigeria and 
the sub-Saharan Africa.
MATERIALS AND METHODS
The study was carried out in the Children Out-
patient (CHOP) Clinic, Children Emergency Unit 
(CHEU), Child Welfare/Growth Monitoring Clinic, 
Immunisation Centre and Paediatric Ward of the 
University of Uyo Teaching Hospital (UUTH), Uyo in 
Akwa-Ibom State. It was conducted over a six month 
period, from November 2010, to April 2011. Uyo, 
the capital city of Akwa Ibom State, is located in the 
south-south region of Nigeria. The Teaching Hospital 
which is the only tertiary healthcare facility is located 
on the outskirts of Uyo six kilometres from the centre 
of the city. The hospital is a three hundred and fifty-
five bed health facility. It serves as a referral centre 
and also accepts self reported cases. Ethical approval 
was obtained from the University of Uyo hospital’s 
ethics committee while the informed consent was 
obtained from parents/guardian of children included 
in the study after initial assessment.
 Included were children with fever or a history of 
fever in the previous 48 hours prior to presentation in 
the hospital with a parasitological proof of P. falciparum 
malaria, and those with one or more features 
of severe malaria such as prostration, repeated 
convulsions, hyperpyrexia, impaired consciousness, 
severe anaemia, respiratory distress, jaundice and 
haemoglobinuria were included. Excluded were 
children with any obvious foci of infection and/or a 
positive blood culture examination and those with 
evidence of chronic illnesses, chronic liver disease, 
inflammatory diseases, viral exanthema and those 
receiving anti-inflammatory drugs.
 During the six month study period, every 
consecutive patient, aged six to sixty months, 
who presented with fever, defined by an axillary 
temperature ≥ 37.50 Celsius (9) or a history of fever 
had a detailed history, general and systemic physical 
examination, including examination of the ears and 
throat. The controls were afebrile, apparently healthy 
children aged six to sixty months, matched for age and 
gender with no clinically identifiable foci of infection 
after a thorough and detailed clinical examination. 
They were selected from children attending child 
welfare clinic for growth monitoring and those 
presenting for immunisation. 
  For every child recruited, thick and thin 
blood films for malaria parasite were prepared 
for confirmation of malaria parasitaemia and 
determination of malaria parasite count. A clinical 
diagnosis of malaria was confirmed on the basis of 
the presence of the asexual forms (trophozoites / 
ring forms) of malaria parasites. A blood culture was 
done on every subject to exclude concurrent bacterial 
infection and a lumbar puncture to exclude meningitis 
in children with altered sensorium, or presenting with 
an episode of seizure.
 The serum C-reactive protein assay was done 
by quantitative determination of C-reactive protein 
using the Enzyme Linked Immunosorbent Assay 
method, (High Sensitivity C-reactive protein Enzyme 
Immunoassay test kit. Catalog number BC-1119, USA) 
(10). The obtained values of the patient samples and 
control sera were multiplied by the dilution factor of 
100 to obtain CRP results in mg/l. 
 The data were analysed using the Statistical 
Package for Social Sciences (SPSS) version 17.0. 
P-value less than 0.05 (p < 0.05) was considered 
statistically significant.
RESULTS
A total of seven hundred and forty-five children 
aged six to sixty months were recruited. Twenty-
three children were excluded from this study for 
different reasons which included eight controls with 
asymptomatic malaria parasitaemia, six patients 
with no malaria parasitaemia, six children with viral 
exanthem and three children who had a positive blood 
culture. Thus, a total of three hundred and sixty (360) 
patients, and three hundred and sixty (360) controls 
were subsequently studied. Among the patients and 
controls studied, 200 (55.6%) were males and 160 
(44.4%) were females giving a male to female ratio 
of 1.25 : 1, Table 1.
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Table 1




Control n (%) Subject n (%) Total n (%)
<12 121 (33.60) 121 (33.60) 242 (33.60)
13 – 24 104 (28.90) 104 (28.90) 208 (28.90)
25 – 36 46 (12.80) 46 (12.80) 93 (12.80)
37 – 48 43 (11.90) 43 (11.90) 84 (11.90)
49 – 60 46 (12.80) 46 (12.80) 93 (12.80)
Gender
Male 200 (55.60%) 200 (55.60%) 360 (100%)
Female 160 (44.40%) 160 (44.40%) 360 (100%)
TOTAL 360 (100.00) 360 (100.00) 720 (100.00)
The mean ages and weights of the male and female 
patients and that of the control group were similar. 
The duration of fever in the patients was one to four 
days (mean 1.9 ± 0.8) and mean temperature 37.83 ± 
0.890Celsius (range 36.5 – 40.10Celsius). No child in 
the control group had fever. The overall mean value 
of serum CRP for the subjects was 11.97 ± 13.97 (range 
0.2 – 70.0mg/l), greater than the 2.21 ± 2.30 (range 
0.2 -10.0mg/l) in the control group. This difference 
was statistically significant (t = 13.09; p< 0.001). There 
was no association between the age (p =0.71), weight 
(p =0.9) and gender (p =0.4) of the subjects in the 
prediction of a CRP response.
 The relative frequency of the manifestations 
of severe malaria in the fifty-five patients depicts 
hyperpyrexia as the most common, in 54 (98.2%), 
prostration in 31 (53.4%), and jaundice the least, in 
three (5.5%) of the 55 patients. Of the seven patients 
presenting with altered sensorium (Blantyre coma 
score < 4), three of these were deeply comatose, 
(Blantyre score of 0 to 2) at presentation, with a 
diagnosis of cerebral malaria. Of the variables, only 
temperature, severe anaemia and hyperparasitaemia 
were independent predictors of a CRP response in 
the patients presenting with severe malaria.
Table 2












Constant -8.616 1.551 -5.554 0.000
Age (months) 0.000 0.001 0.0004 0.104 0.917
Temperature 0.252 0.037 0.468 6.867 0.001*
Prostration 0.073 0.101 0.043 0.726 0.468
Impaired consciousness
0.073 0.160 0.021 0.455 0.649
Hyperpyrexia
0.014 0.098 0.011 0.148 0.883
Multiple convulsions
-0.051 0.132 -0.017 -0.388 0.698
Severe anaemia -36.38 2.237 0.521 -11.23 0.001*
Hypoglycaemia 3.11 5.52 0.026 0.56 0.57
Malaria parasite count 0.148 0.028 0.283 5.387 0.001*
Duration of fever 0.015 0.026 0.024 0.581 0.562
*Statistically significant
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Table 3
Distribution of the malaria parasite count and serum CRP levels in the patients.
Malaria parasite count/µl 
(range)
n C-reactive protein (mg/l) 
Mean ± S.D
Mean difference F (p value)
500 – 5000 195 5.96 ± 7.01 87.13 (0.001)
>5000 – 100,000 86 11.43 ± 10.97 -5.47 (0.001)*
>100,000 – 250,000 72 25.20 ± 16.73 -16.59 (0.001)*
> 250,000 7 49.71 ± 10.79 -36.62 (0.001)*
Total 360 11.97 ± 13.96
ANOVA       F = 87.13; p = 0.001 
*Statistically significant
Table 4
Mean Serum C-reactive protein levels and temperature pattern in patients
Temperature N CRP (Mean ± S.D) Mean difference F (p-value)
Afebrile 144 4.13 ± 5.07 156.82 (0.001)
Pyrexia 162 11.67 ± 10.35 -7.67 (0.001)*
Hyperpyrexia 54 32.84 ± 17.40 -28.71 (0.001)*
*Statistically significant
Table 5
Mean serum C-reactive protein and duration of fever in patients
Duration of fever (days) N CRP (Mean ± SD) Mean difference F (p-value)
1 120 10.34 ± 11.77 0.81 (0.48)
2 164 12.83 ± 14.83 1.67 (0.53)
3 68 12.69 ± 15.74 2.12 (0.74)
4 8 12.95 ± 9.02 5.10 (0.98)
The logistic regression model in Table 2 showed 
that the significant predictors of a C-reactive protein 
response in malaria were the malaria parasite count (t 
= 5.387; p = 0.001), temperature (t = 6.867; p = 0.001) 
and severe anaemia (t = -11.23, p = 0.001). The other 
clinical variables were not significant predictors of 
a CRP response. The logistic model had a 66.92% 
sensitivity, 92.07% specificity, negative predictive 
value of 82.16% and positive predictive value of 
83.18% of predicting elevation of C-reactive protein 
in children with malaria.
 The distribution of the malaria parasite count 
and serum C-reactive protein levels in the subjects is 
shown in Table  3. The subjects with hyperparasitaemia 
(>250,000 parasites/µl) had the highest mean serum 
C-reactive protein level. The parasite count was a 
significant predictor of a CRP response in patients and 
this was significantly higher in children with severe 
than uncomplicated malaria (t = -7.24; p<0.001). 
 Table 4 shows temperature as a significant 
predictor of a CRP response. A significant difference 
in the mean serum C-reactive protein level (mg/l) 
occurred in the subjects as temperature increased 
using the analysis of one way variance (ANOVA). 
Subjects who presented with hyperpyrexia had 
greater mean serum CRP level of 32.84 ± 17.40 than 
the 11.67 ± 10.35mg/l in subjects with fever and that 
in afebrile subjects (4.13 ± 5.07), (F = 156.82; p = 0.001). 
There was however, no significant difference between 
the mean serum CRP levels and the duration of fever 
at presentation (t = 0.81; p = 0.48)  Table 5.
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Figure 1
Pattern of C-reactive protein response in study population.
Figure 2 shows that one hundred and thirty-three 
(36.9%) of the 360 patients with malaria had a CRP 
response (CRP ≥ 10mg/l), while only six (4.32%) of 
the 360 controls had a CRP response (P < 0.001). This 
pattern of CRP response indicated that children with 
a C-reactive protein level ≥10mg/l were twenty-two 
times more likely to be infected with malaria [chi-
square (p-value); 143.79 (0.001) OR =1.29; RR =22.16)].
DISCUSSION
This study demonstrated the presence of a greater 
C-reactive response in the malaria infected children 
than in the controls. This was consistent with findings 
by other authors (11,12) who acknowledged a greater 
concentration of C-reactive protein in the sera of 
children infected with plasmodium falciparum malaria. 
The malaria-attributable CRP response of 36.9% 
obtained in this study was lower than the 51.7% 
documented in Tanzanian children (13), but higher 
than the 8.2% documented in children residing in 
Papua New Guinea (14). The difference in reports may 
be because the study in Tanzanian children (13) was 
community based, and in a hyperendemic malaria 
region. Moreover, children with bacterial infections 
were not excluded. This could have provoked a 
greater induction of CRP response. Imrie et al (14) 
in Papua new guinea studied only healthy children 
with asymptomatic low-grade parasitaemia. This 
probably explains the lower prevalence obtained 
from the Papuan children.
It has been established that CRP responses are 
greater in children presenting with the acute 
phase of uncomplicated or severe malaria than in 
asymptomatic children. This is as a result of the greater 
release of bioactive molecules, and host inflammatory 
response including cytokine production (15-17).  Also, 
there is a genetic predisposition to the secretion of 
CRP in malaria and this is demonstrated in varying 
degrees in different population groups (18,19).
 The comparatively low level of CRP response in 
control children in this study was similar to reports by 
Riberio (11) in Brazil and Kindmark (12) in Sweden 
in their study populations of healthy children. The 
trauma prone tendencies common in young children, 
with accompanying injuries and also sub-clinical 
infections not usually obvious on clinical examination 
could all elicit these varying degrees of C-reactive 
protein resp.
 The higher levels of mean serum CRP 
concentration between the subjects and controls in 
the various age groups in present study reinforces 
the effect of malaria antigen in the induction of CRP 
production (20,21). Younger children mostly under 
two years of age constituted a greater percentage 
(62.5%) of the patients in this study. These children, 
who though live in a holoendemic region are yet 
to develop full malaria immunity which comes 
from prolonged and repeated exposure to malaria 
parasitaemia. They therefore elicited a more marked 
immune and inflammatory response to invading 
parasitaemia reflecting in their greater CRP levels. 
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Acquired malarial immunity is known to play an 
important role in the modulation of the immune 
responses to invading parasites (22,23).
 The significantly higher response observed in the 
febrile patients compared with the afebrile ones was 
similar to studies in other African children (13,14). 
In Tanzania, Hurt et al (13) documented this trend of 
significantly increasing serum CRP levels in children 
with temperatures greater than 37.4ºC. The reason 
for this observation may be explained by the greater 
parasite densities and corresponding cytokine release 
from the macrophage response. These cytokines 
including interleukins 1 and 6, tumour necrosis factor 
are also responsible for the stimulation of CRP in 
malaria as well as fever (24,25).
 The lack of a significant difference between the 
mean serum CRP levels and the duration of fever in the 
patients presenting in the present study indicates that 
once the stimulus for induction of CRP is triggered, 
the secretion of CRP is sustained, irrespective of the 
temperature periodicity, as occurs in malaria. Serum 
CRP levels gradually and slowly rises with the level of 
parasitaemia and cytokine release. The present study 
suggests that increased levels of CRP may also occur 
in clinical episodes of malaria which symptoms do 
not include a measurable fever. This indicates that 
CRP levels reflect recent histories of fever as well as 
the current episodes (13). This is a useful finding for 
malaria epidemiological surveys, and may accurately 
present malaria morbidities in a given population.
 The study indicates a moderate CRP response in 
children with malaria, especially younger children, 
those with hyperparasitaemia, severe anaemia and 
hyperpyrexia. This is a useful test in identifying 
children with a risk to life-threatening manifestations 
such that prompt and appropriate treatment can 
be instituted. Larger scale studies which include 
more severe cases of malaria may indicate more 
independent predictors of the CRP response in 
malaria. 
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